NCCN Guidelines® Insights: Breast Cancer Screening and Diagnosis, Version 1.2023.
J Natl Compr Canc Netw
; 21(9): 900-909, 2023 09.
Article
em En
| MEDLINE
| ID: mdl-37673117
ABSTRACT
The NCCN Guidelines for Breast Cancer Screening and Diagnosis provide health care providers with a practical, consistent framework for screening and evaluating a spectrum of clinical presentations and breast lesions. The NCCN Breast Cancer Screening and Diagnosis Panel is composed of a multidisciplinary team of experts in the field, including representation from medical oncology, gynecologic oncology, surgical oncology, internal medicine, family practice, preventive medicine, pathology, diagnostic and interventional radiology, as well as patient advocacy. The NCCN Breast Cancer Screening and Diagnosis Panel meets at least annually to review emerging data and comments from reviewers within their institutions to guide updates to existing recommendations. These NCCN Guidelines Insights summarize the panel's decision-making and discussion surrounding the most recent updates to the guideline's screening recommendations.
Texto completo:
1
Coleções:
01-internacional
Temas:
Atencao_primaria_forma_integrada
Base de dados:
MEDLINE
Assunto principal:
Neoplasias da Mama
/
Detecção Precoce de Câncer
Tipo de estudo:
Diagnostic_studies
/
Guideline
/
Prognostic_studies
/
Qualitative_research
/
Screening_studies
Limite:
Female
/
Humans
Idioma:
En
Revista:
J Natl Compr Canc Netw
Ano de publicação:
2023
Tipo de documento:
Article